A Vita
Overview
Explore the profile of A Vita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
1148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baune B, Fromme S, Aberg M, Adli M, Afantitis A, Akkouh I, et al.
Eur Arch Psychiatry Clin Neurosci
. 2024 Dec;
PMID: 39729102
Schizophrenia (SCZ), bipolar (BD) and major depression disorder (MDD) are severe psychiatric disorders that are challenging to treat, often leading to treatment resistance (TR). It is crucial to develop effective...
2.
DellOsso L, Amatori G, Massimetti G, Nardi B, Gravina D, Benedetti F, et al.
Eur Psychiatry
. 2022 Nov;
65(1):e81.
PMID: 36328964
Background: In recent years, numerous studies have highlighted the overlap between autism spectrum disorder (ASD) and catatonia, both from a clinical and pathophysiological perspective. This study aimed to investigate the...
3.
4.
Heerlein K, De Giorgi S, Degraeve G, Frodl T, Hagedoorn W, Oliveira-Maia A, et al.
J Affect Disord
. 2021 Nov;
298(Pt A):442-450.
PMID: 34742998
Background: Treatment resistant depression (TRD) is diagnosed when patients experiencing a major depressive episode fail to respond to ≥2 treatments. Along with substantial indirect costs, patients with TRD have higher...
5.
Magni L, Ferrari C, Barlati S, Ridolfi M, Prunetti E, Vanni G, et al.
Psychiatry Res
. 2020 Nov;
295:113556.
PMID: 33189367
Psychotherapy is the cornerstone of treatment for borderline personality disorder (BPD) while pharmacotherapy should be considered only as an adjunctive intervention. In clinical practice, however, most of BPD patients only...
6.
Clerici M, DUrbano F, Spinogatti F, Vita A, de Girolamo G, Micciolo R
Ir J Psychol Med
. 2020 May;
37(4):283-290.
PMID: 32368994
Objectives.: To assess admission rates to seven General Hospital Psychiatric Wards (GHPWs) located in the Lombardy Region in the 40 days after the start of Coronavirus disease 2019 (COVID-19) epidemic,...
7.
Vita A, Perin A, Cavanna M, Cobelli F, Rosa J, Valsecchi P, et al.
Schizophr Res
. 2019 Dec;
216:243-248.
PMID: 31818634
Negative symptoms of schizophrenia have a great impact on patients' functioning and are among the most important contributors to subject's disability. However, few studies have assessed the role of type...
8.
Fagiolini A, Aguglia E, Ballerini A, Callista G, Carpiniello B, Clerici M, et al.
Psychiatry Res
. 2019 Mar;
272:698-706.
PMID: 30832189
Objectives: To identify the variables that are associated with persistence to Aripiprazole-Long Acting (A-LAI), in adult patients with schizophrenia. Methods: Observational, retrospective, non-interventional study involving 261 patients with schizophrenia. Results:...
9.
Bucci P, Galderisi S, Mucci A, Rossi A, Rocca P, Bertolino A, et al.
Acta Psychiatr Scand
. 2018 Jul;
138(3):253-266.
PMID: 29984409
Objective: The study aimed to explore premorbid academic and social functioning in patients with schizophrenia, and its associations with the severity of negative symptoms and neurocognitive impairment. Method: Premorbid adjustment...
10.
Rocca P, Galderisi S, Rossi A, Bertolino A, Rucci P, Gibertoni D, et al.
Schizophr Res
. 2018 Jun;
201:105-112.
PMID: 29898819
Background: A general consensus has not yet been reached regarding the role of disorganization symptoms in real-world functioning in schizophrenia. Methods: We used structural equations modeling (SEM) to analyze the...